Orthobiologics Market Analysis, Strategies With Forecasts To 2025

Orthobiologics Market Analysis, Strategies With
Forecasts To 2025
“The global orthobiologics market is poised for growth owing to the increased levels of
geriatric population, technological advancements, changing lifestyles and problems
related to the musculoskeletal system. The increasing trends of musculoskeletal
procedures are seen to be the biggest driver for the market. "
Global Orthobiologics Market report provides in-depth analysis and insights into developments impacting businesses
and enterprises on global and regional level. The report covers the global Orthobiologics Market performance in terms
of revenue contribution from various segments and includes a detailed analysis of key trends, drivers, restraints, and
opportunities influencing revenue growth of the global Orthobiologics market. This report studies the global
Orthobiologics Market size, industry status and forecast, competition landscape and growth opportunity. This research
report categorizes the global Orthobiologics Market by companies, region, type and end-use industry.
The global orthobiologics market size was valued at USD 5.0 Billion in 2015 and is anticipated to reach USD 10.2 billion
by 2025, with a CAGR of 7.5%. Orthobiologics are elements which the orthopedic surgeons use to heal the wounds more
quickly. They are utilized for the healing of injured muscles, ligaments, tendons, and broken bones. They are made up of
substances found in the human body itself. These elements found popularity owing to factor such as faster healing,
quick recovery, and a decrease in the number of hospital visits. The orthobiologics market provides a huge number of
opportunities for growth to its shareholders.
The global orthobiologics market is poised for growth owing to the increased levels of geriatric population, technological
advancements, changing lifestyles and problems related to the musculoskeletal system. The increasing trends of
musculoskeletal procedures are seen to be the biggest driver for the market. Establishing strategic partnerships for the
purpose of marketing is also expected to boost the demand for the global orthobiologics market. Several merchants are
forming strategic partnerships to diversify their businesses, grow their overall market share and spread out their product
offerings. These type of strategic alliances help the organizations to align their technologies with one another’s inventive
medical device range.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/orthobiologics-market/request-sample

A growth in the global orthobiologics market is projected on account of the requirement for safer, more effective and
modern orthopedic biologic treatment. The rise in the number of obesity and arthritis cases also fuels the demand for
orthobiologics treatment. The bone graft procedure accounted to be the largest segment in the global orthobiologics
market.
The shifting preference to biological implants from mechanical implants is accelerating the growth of this market.
Another important trend that is estimated to enhance the growth of the market over next eight years is the increase in
funds to improve orthobiologics. Factors such as growing advances in technology, the prevalence of a h uge number of
chronic and unidentified diseases, initiatives by the government and rise in life expectation may favorably impact the
market growth. Along with this, the rising incidences of injuries by sports & road accidents and growing awareness
among athletes are also driving the demand for the market.
However, lack of clear reimbursement procedures and rigorous rules may create major hindrances for the orthobiologics
demand in the market. The improvements in developing alternatives for pharmaceuticals, for making medical
treatments more preventive than curative along with the country’s policy for decreasing the deficit in the budget is
expected to negatively impact the global orthobiologics market. Furthermore, high costs for the procedure, lack of
reliable clinical trial data and strict regulations for the approval of orthobiologics products may pose challenges to the
market growth over the forecast period.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/orthobiologics-market
The global orthobiologics market has been segmented based on its applications and product types. On the basis of
application, the market been classified into spinal surgery, joint replacement & reconstruction, and trauma surgery. On
the basis of product types, the market has been segmented into bone graft substitutes, bone growth stimulators, and
viscosupplements. The bone graft substitutes have further been segmented into demoralized bone matrix (DBM), bone
morph genic proteins (BMP), bone allografts, and bone autographs. Additionally, viscosupplements has also been
further segmented into single injection viscosupplements, 3-injection viscosupplements, and 5-injection
viscosupplements.
Over the past few years, the viscosupplements segments held the largest market share for orthobiologics on account of
huge demand for knee treatment procedures. It is a very effective pain killer. Viscosupplements are intra-articular
injections made of hyaluronic acid which helps in the treatment of osteoarthritis.
North America held the majority of the global orthobiologics market in the recent past. The high demand in the market
was sustained by increased prevalence of arthritis and obesity in the region, rising demand for the treatment of various
diseases such as osteoarthritis and spinal injuries. However, over the next eight years, Asia-Pacific is projected to witness
the highest rate of growth for orthobiologics market. This growth will be majorly driven by the Indian and Chinese
market on account of a huge number of untapped patient population, economical cost, and medical tourism.

The major industry players operating in the global orthobiologics market include Stryker Corporation, Synthes, Inc.,
Biomet, Inc., DJO Global, Zimmer Holding, Inc., Medtronic, Inc., and Smith & Nephew, Bacterin International, Inc.,
DePuySynthes, Inc., Globus Medical, Inc., and Integra LifeSciences Corporation.
Market Segment:
Orthobiologics Product Outlook (Revenue, USD Billion, 2014 - 2025)
• Demineralized Bone Matrix(DBM)
• Allograft
• Bone Morphogenetic Protein (BMP)
• Viscosupplementation
• Synthetic Bone Substitutes
• Stem Cell Therapy
Orthobiologics Application Outlook (Revenue, USD Billion, 2014 - 2025)
• Spinal Fusion
• Trauma Repair
• Reconstructive Surgery
Orthobiologics End-use Outlook (Revenue, USD Billion, 2014 - 2025)
• Hospitals
• Orthopedic Clinics
Orthobiologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
• North America
• U.S
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• Middle East and Africa
• South Africa
See More Reports of this Category by Million Insights @
https://www.millioninsights.com/industry/biotechnology

Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction.
Our representatives strive to understand diverse client requirements and cater to the same with
the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: ryan@millioninsights.com
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: sales@millioninsights.com
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016
India
Phone: 91-20-65300184